tirzepatide surmount 2 SURMOUNT‐4 study design. This is a phase 3, multicenter, randomized, SURMOUNT-1 Trial - Cardionerds Twitter

Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters

doi: 10.1016/j.tips.2014.02.001 Summary Keywords MASLD, metabolic dysregulation, genetic polymorphisms, clinical management, precision medicine Citation Ma J, Ma Y, Wan X, Li J, Zhang Y, Liu J and Gao Y (2025) Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges

Intralesional agents in the management of cutaneous malignancy: a review

Illustrative Case Case Presentation The present case concerns a 48-year-old ambidextrous male who presented with left-sided flank pain for approximately 6 months, which eventually progressed to his right side

As the IV push vs IV infusion (drip) method is fast, clients dont need to take more than 15 minutes out from their daily schedule to undergo an IV push injection

For those facing challenges in shedding pounds, prescription options for weight management can offer valuable assistance